Skip to content
Stop using now Drug recall · FDA · Published April 25, 2024

Sagent MethylPREDNISolone Acetate Injectable Suspension Recall: Black Particulates Risk

Sagent Pharmaceuticals recalls 400mg/10mL MethylPREDNISolone Acetate Injectable Suspension vials due to potential black particulates. Affected lots manufactured in India, expiring Jan 2025. Stop using immediately.

🇺🇸 FDA recall #D-0499-2024DrugSagent Pharmaceuticals ›
Take action

Contact the company

Recalling firmSagent Pharmaceuticals1901 N Roselle Rd Ste 450 · Schaumburg, IL 60195
✎ GovInfoNow plain-language explainer

What happened, in plain English

Sagent Pharmaceuticals is recalling a specific injectable steroid medication vial because it may contain black particles. This could cause serious injury if injected. The recall affects vials with specific lot numbers made in India. Read more at govinfonow.com/recall/32707-sagent-methylprednisolone-acetate-injectable-suspension-recall-black-particulates-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/32707-sagent-methylprednisolone-acetate-injectable-suspension-recall-black-particulates-risk · Updated August 17, 2026 · FDA enforcement record: FDA #D-0499-2024

Cite this page

“Sagent MethylPREDNISolone Acetate Injectable Suspension Recall: Black Particulates Risk.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32707-sagent-methylprednisolone-acetate-injectable-suspension-recall-black-particulates-risk. Based on FDA recall #D-0499-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0499-2024%22&limit=1).

Why it’s dangerous

Black particles in the injectable medication could cause serious injury or death when administered. Particulate matter in injectable drugs is a known hazard as it may clog blood vessels or cause tissue damage.

Who’s affected

Prescription patients using the recalled vial for steroid treatment. Those with the specific lot numbers (5100186-5100189) manufactured in India are most at risk.

How to tell if you have this one

Check for vials labeled 'MethylPREDNISolone Acetate Injectable Suspension, USP, 400 mg per 10 mL (40 mg per mL), 1 x 10 mL Multi-Dose Vial'. Look for lot numbers 5100186 through 5100189 made in India, expiring January 2025.

  • Brand
    Sagent Pharmaceuticals
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Stop Using Immediately

    Discard the vial if you have the recalled lot numbers (5100186-5100189) manufactured in India.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 27 days after the firm started it.

1. Firm started the recall: Apr 25, 202412. FDA classified it Class II: May 15, 202423. Published in FDA’s Enforcement Report: May 22, 202432024
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0499-2024 (April 25, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0499-2024 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA